The last time The Lancet Microbe featured an Editorial on CRISPR was in November 2020, to mark that year’s Nobel Prize in Chemistry, jointly awarded to Emmanuelle Charpentier and Jennifer A Doudna for their work developing CRISPR-Cas9 genome editing technology.
The Lancet Microbe (Wed,) studied this question.